ENHYPEN entered 2026 with a series of record-breaking achievements. The 7-member group has already made a successful comeback and is continuing their activities.
On August 16, 2025, ENHYPEN performed at the 22,000-seat BMO Stadium in Los Angeles as part of their “Walk the Line World Tour.” The show grossed $4.121 million, the group’s highest-grossing concert in the United States to date. With this, ENHYPEN became the first group and the first Asian artist who debuted in the 2020s to earn over $4 million from a single U.S. concert.
The Los Angeles concert was part of the Walk the Line World Tour, which ran from October 2024 to October last year and included more than 25 shows across Asia, the U.S., and Europe. The tour grossed a total of $76.1 million, one of the top K-pop tours of 2025 according to Billboard Boxscore.
Other records from the tour include the highest single-show attendance of 42,934 tickets sold on the first day of the Osaka Summer Edition. The all-time tour gross record of $5.072 million was for their Bangkok concert at Rajamangala Stadium.
More recently, they released their latest mini-album, “THE SIN : VANISH,” which took second place on the Billboard 200. It was ENHYPEN’s fifth consecutive Top 5 entry on the U.S. chart.
The album, released on January 16, 2026, sold 1.65 million copies in its first 24 hours, the top-selling K-pop album of 2026 at the time. The lead single, “Knife,” also made an impact with around 1.5 million streams on the Global Spotify Daily chart.
Looking ahead, their Walk the Line Summer Edition concert in Japan will be released as a cinematic experience. The film, featuring live performances and behind-the-scenes footage, is slated for March 5 and 7, 2026.
While no official dates have been announced, ENHYPEN is expected to launch a new and even larger world tour in 2026, likely visiting major cities in Asia, North America, Europe, and Latin America, with upgraded production and staging.
